Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 178075, 8 pages
http://dx.doi.org/10.1155/2014/178075
Review Article

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment

Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo 160-8582, Japan

Received 12 October 2013; Accepted 8 December 2013; Published 2 January 2014

Academic Editors: M. Ferracin, P. Momigliano Richiardi, and K. Pelin

Copyright © 2014 Kouji Banno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Reshmi and M. R. Pillai, “Beyond HPV: oncomirs as new players in cervical cancer,” FEBS Letters, vol. 582, no. 30, pp. 4113–4116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Matsuda, T. Marugame, K.-I. Kamo, K. Katanoda, W. Ajiki, and T. Sobue, “Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project,” Japanese Journal of Clinical Oncology, vol. 41, no. 1, pp. 139–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Banno, M. Yanokura, I. Kisu, W. Yamagami, N. Susumu, and D. Aoki, “MicroRNAs in endometrial cancer,” International Journal of Clinical Oncology, vol. 18, no. 2, pp. 186–192, 2013. View at Publisher · View at Google Scholar
  4. A. Torres, K. Torres, R. Maciejewski, and W. H. Harvey, “MicroRNAs and their role in gynecological tumors,” Medicinal Research Reviews, vol. 31, no. 6, pp. 895–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Narisawa-Saito and T. Kiyono, “Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins,” Cancer Science, vol. 98, no. 10, pp. 1505–1511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Yugawa and T. Kiyono, “Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses,” Uirusu, vol. 58, no. 2, pp. 141–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. L. Howie, R. A. Katzenellenbogen, and D. A. Galloway, “Papillomavirus E6 proteins,” Virology, vol. 384, no. 2, pp. 324–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Gewin, H. Myers, T. Kiyono, and D. A. Galloway, “Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex,” Genes and Development, vol. 18, no. 18, pp. 2269–2282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kiyono, A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi, “Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11612–11616, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ghittoni, R. Accardi, U. Hasan, T. Gheit, B. Sylla, and M. Tommasino, “The biological properties of E6 and E7 oncoproteins from human papillomaviruses,” Virus Genes, vol. 40, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Georges, M. C. Biery, S.-Y. Kim et al., “Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215,” Cancer Research, vol. 68, no. 24, pp. 10105–10112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. J. Braun, X. Zhang, I. Savelyeva et al., “p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest,” Cancer Research, vol. 68, no. 24, pp. 10094–10104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-L. Yan, G. Xue, Q. Mei et al., “Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis,” EMBO Journal, vol. 28, no. 18, pp. 2719–2732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-Y. Park, J. H. Lee, M. Ha, J.-W. Nam, and V. N. Kim, “miR-29 miRNAs activate p53 by targeting p85α and CDC42,” Nature Structural and Molecular Biology, vol. 16, no. 1, pp. 23–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Fornari, L. Gramantieri, C. Giovannini et al., “MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells,” Cancer Research, vol. 69, no. 14, pp. 5761–5777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. T. Le, C. Teh, N. Shyh-Chang et al., “MicroRNA-125b is a novel negative regulator of p53,” Genes and Development, vol. 23, no. 7, pp. 862–876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik, “MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells,” Cancer Research, vol. 68, no. 19, pp. 8164–8172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. P. M. Voorhoeve, C. le Sage, M. Schrier et al., “A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors,” Cell, vol. 124, no. 6, pp. 1169–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Yao, H. Xu, Q.-Q. Zhang, H. Zhou, and L.-H. Qu, “MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells,” Biochemical and Biophysical Research Communications, vol. 388, no. 3, pp. 539–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yao and Z. Lin, “MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20,” Biochimica et Biophysica Acta, vol. 1822, no. 2, pp. 248–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Long, F. X. Wu, P. Li, M. Liu, X. Li, and H. Tang, “MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells,” Cancer Letters, vol. 324, no. 2, pp. 186–196, 2012. View at Publisher · View at Google Scholar
  24. X. M. Xu, X. B. Wang, M. M. Chen et al., “MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5,” Cancer Letters, vol. 322, no. 2, pp. 148–158, 2012. View at Publisher · View at Google Scholar
  25. H.-W. Kang, F. Wang, Q. Wei et al., “miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells,” FEBS Letters, vol. 586, no. 6, pp. 897–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Qin, P. Dong, C. Ma et al., “MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways,” Oncogene, vol. 31, no. 36, pp. 4067–4075, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Chakrabarti, N. L. Banik, and S. K. Ray, “miR-138 overexpression is more than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo,” Experimental Cell Research, vol. 319, no. 10, pp. 1575–1585, 2013. View at Publisher · View at Google Scholar
  28. S. Liu, P. Zhang, Z. Chen, M. Liu, X. Li, and H. Tang, “MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells,” FEBS Letters, vol. 587, no. 14, pp. 2247–2253, 2013. View at Publisher · View at Google Scholar
  29. Q. Wei, Y. X. Li, M. Liu, X. Li, and H. Tang, “MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells,” IUBMB Life, vol. 64, no. 8, pp. 697–704, 2012. View at Publisher · View at Google Scholar
  30. F. Cui, X. Li, X. Zhu et al., “MiR-125b inhibits tumor growth and promotes apoptosis of cervix cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta,” Cellular Physiology and Biochemistry, vol. 30, no. 5, pp. 1310–1318, 2012. View at Publisher · View at Google Scholar
  31. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, “Secretory mechanisms and intercellular transfer of microRNAs in living cells,” Journal of Biological Chemistry, vol. 285, no. 23, pp. 17442–17452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Kosaka, H. Izumi, K. Sekine, and T. Ochiya, “MicroRNA as a new immune-regulatory agent in breast milk,” Silence, vol. 1, no. 1, article 7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Kosaka, H. Iguchi, and T. Ochiya, “Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis,” Cancer Science, vol. 101, no. 10, pp. 2087–2092, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Gilad, E. Meiri, Y. Yogev et al., “Serum microRNAs are promising novel biomarkers,” PLoS One, vol. 3, no. 9, Article ID e3148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. C. H. Lawrie, S. Gal, H. M. Dunlop et al., “Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma,” British Journal of Haematology, vol. 141, no. 5, pp. 672–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Gocze, K. Gombos, K. Juhasz et al., “Unique microRNA expression profiles in cervical cancer,” Anticancer Research, vol. 33, no. 6, pp. 2561–2567, 2013. View at Google Scholar
  39. S. Zhao, D. Yao, J. Chen, and N. Ding, “Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer,” Genetic Testing and Molecular Biomarkers, vol. 17, no. 8, pp. 631–636, 2013. View at Publisher · View at Google Scholar
  40. S. Zhao, D. S. Yao, J. Y. Chen, and N. Ding, “Aberrant expression of miR-20a and miR-203 in cervical cancer,” Asian Pacific Journal of Cancer, vol. 14, no. 4, pp. 2289–2293, 2013. View at Publisher · View at Google Scholar
  41. J. Chen, D. Yao, Y. Li et al., “Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma,” International Journal of Molecular Medicine, vol. 32, no. 3, pp. 557–567, 2013. View at Publisher · View at Google Scholar
  42. L. Huang, J.-X. Lin, Y.-H. Yu, M.-Y. Zhang, H.-Y. Wang, and M. Zheng, “Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix,” PLoS One, vol. 7, no. 3, Article ID e33762, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. M. Wilting, R. A. van Boerdonk, F. E. Henken et al., “Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer,” Molecular Cancer, vol. 9, article 167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Yao, Q. Rao, L. Liu et al., “Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer,” Journal of Virology, vol. 10, article 175, 2013. View at Publisher · View at Google Scholar
  45. S. M. Wilting, W. Verlaat, A. Jaspers et al., “Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis,” Epigenetics, vol. 8, no. 2, pp. 220–228, 2013. View at Publisher · View at Google Scholar
  46. T. Ochiya, Y. Takahama, S. Nagahara et al., “New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet,” Nature Medicine, vol. 5, no. 6, pp. 707–710, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Li and F. C. Szoka Jr., “Lipid-based nanoparticles for nucleic acid delivery,” Pharmaceutical Research, vol. 24, no. 3, pp. 438–449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Shiba, H. Masuda, N. Watanabe et al., “Chemical synthesis of a very long oligoribonucleotide with 2-cyanoethoxymethyl (CEM) as the 2′-O-protecting group: structural identification and biological activity of a synthetic 110mer precursor-microRNA candidate,” Nucleic Acids Research, vol. 35, no. 10, pp. 3287–3296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. P. S. Linsley, J. Schelter, J. Burchard et al., “Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression,” Molecular and Cellular Biology, vol. 27, no. 6, pp. 2240–2252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Osaki, F. Takeshita, and T. Ochiya, “MicroRNAs as biomarkers and therapeutic drugs in human cancer,” Biomarkers, vol. 13, no. 7-8, pp. 658–670, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Liu, X. Yu, X. Guo et al., “miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2,” Molecular Medicine Reports, vol. 5, no. 3, pp. 753–760, 2012. View at Publisher · View at Google Scholar
  52. X. M. Wang, J. Xu, Z. Q. Cheng et al., “Study on effects of microRNA-21 antisense oligonucleotide in vivo and in vitro on bionomics of human cervical squamous carcinoma cell lines SiHa,” Chinese Journal of Pathology, vol. 41, no. 4, pp. 254–259, 2012. View at Publisher · View at Google Scholar
  53. T. Haraguchi, Y. Ozaki, and H. Iba, “Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells,” Nucleic Acids Research, vol. 37, no. 6, article e43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. N. H. Phuah, L. L. In, M. N. Azmi, H. Ibrahim, K. Awang, and N. H. Nagoor, “Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1′S-1′-acetoxychavicol acetate and cisplatin,” Reproductive Sciences, vol. 20, no. 5, pp. 567–578, 2013. View at Publisher · View at Google Scholar
  55. C. Lei, Y. Wang, Y. Huang et al., “Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells,” PloS One, vol. 7, no. 12, Article ID e52310, 2012. View at Publisher · View at Google Scholar
  56. F. Wang, M. Liu, X. Li, and H. Tang, “MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells,” FEBS Letters, vol. 587, no. 5, pp. 488–495, 2013. View at Publisher · View at Google Scholar
  57. J. Li, Z. Ping, and H. Ning, “MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 16053–16064, 2012. View at Publisher · View at Google Scholar
  58. Y. Shen, P. Wang, Y. Li et al., “miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer,” British Journal of Cancer, vol. 109, no. 1, pp. 92–99, 2013. View at Publisher · View at Google Scholar
  59. G. Ke, L. Liang, J. M. Yang et al., “MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene,” Oncogene, vol. 32, no. 25, pp. 3019–3027, 2013. View at Publisher · View at Google Scholar